These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 19290794

  • 1. Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease.
    Rudnicki M, Mayer G.
    Pharmacogenomics; 2009 Mar; 10(3):463-76. PubMed ID: 19290794
    [Abstract] [Full Text] [Related]

  • 2. Gene polymorphism of the renin-angiotensin system and progression of diabetic nephropathy.
    Orisio S.
    J Nephrol; 1999 Mar; 12(1):9-17. PubMed ID: 10202997
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U, Schmidt A, Illievich A, Kiener HP, Rabensteiner D, Kaider A, Prager R, Abrahamian H, Irsigler K, Mayer G.
    Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY, Chen LS, Zhang LC, Zhou TB.
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [Abstract] [Full Text] [Related]

  • 7. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P, Majkowska L, Safranow K, Adler G, Goracy I.
    Przegl Lek; 2007 Jul; 64(3):134-9. PubMed ID: 17941464
    [Abstract] [Full Text] [Related]

  • 8. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
    Wong TY, Szeto CC, Chow KM, Chan JC, Li PK.
    Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175
    [Abstract] [Full Text] [Related]

  • 9. ACE genotype and ACE inhibitor response in kidney disease: a perspective.
    Mayer G.
    Am J Kidney Dis; 2002 Aug; 40(2):227-35. PubMed ID: 12148094
    [Abstract] [Full Text] [Related]

  • 10. Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age.
    Franco E, Palumbo L, Crobu F, Anselmino M, Frea S, Matullo G, Piazza A, Trevi GP, Bergerone S.
    BMC Med Genet; 2007 May 22; 8():27. PubMed ID: 17519002
    [Abstract] [Full Text] [Related]

  • 11. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
    Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F.
    J Clin Invest; 1997 Apr 01; 99(7):1585-95. PubMed ID: 9120002
    [Abstract] [Full Text] [Related]

  • 12. [Genetic factors with significance in pathogenesis of diabetic nephropathy--the role of polymorphism of renin-angiotensin system genes].
    Grzeszczak W.
    Przegl Lek; 2000 Apr 01; 57 Suppl 3():19-24. PubMed ID: 11293230
    [Abstract] [Full Text] [Related]

  • 13. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
    Singapore Med J; 2008 Nov 01; 49(11):924-9. PubMed ID: 19037561
    [Abstract] [Full Text] [Related]

  • 14. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
    Böger CA, Götz AK, Krüger B, Hösl M, Schmitz G, Riegger GA, Krämer BK.
    Eur J Med Res; 2005 Apr 20; 10(4):161-8. PubMed ID: 15946912
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.
    Ruggenenti P, Bettinaglio P, Pinares F, Remuzzi G.
    Clin J Am Soc Nephrol; 2008 Sep 20; 3(5):1511-25. PubMed ID: 18550651
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of angiotensin-converting enzyme insertion-deletion polymorphism on progression of renal and cardiovascular diseases].
    Reiterová J, Tesar V, Merta M.
    Cas Lek Cesk; 2001 May 20; 140(9):267-71. PubMed ID: 11417193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.